• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge

cafead

Administrator
Staff member
  • cafead   May 01, 2018 at 09:22: PM
via Last week, the Bill and Melinda Gates Foundation announced that it plans to provide researchers with up to $12 million in funding as part of a new initiative to support the development of a universal influenza vaccine.

However, the Gates Foundation’s commitment to improving on the status quo in flu vaccines underscores the threat a major flu outbreak would pose to public health, says Paul Radspinner. He’s the co-founder and CEO of FluGen, a Madison, WI-based startup that develops flu vaccine candidates designed to protect against multiple strains of the disease.

article source